European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis
Publication date
2020-06-01
Authors
Wollenberg, A
Flohr, C
Simon, D
Cork, M J
Thyssen, J P
Bieber, T
de Bruin-Weller, Marjolein
Weidinger, S
Deleuran, M
Taieb, A
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Advisory Committees, COVID-19, Comorbidity, Coronavirus Infections/epidemiology, Dermatitis, Atopic/drug therapy, Europe, Female, Humans, Immunocompromised Host/drug effects, Immunosuppressive Agents/therapeutic use, Male, Pandemics, Pneumonia, Viral/epidemiology, Practice Guidelines as Topic, Risk Assessment, Severe Acute Respiratory Syndrome/epidemiology, Treatment Outcome, Taverne, Letter, Review
Citation
Wollenberg, A, Flohr, C, Simon, D, Cork, M J, Thyssen, J P, Bieber, T, de Bruin-Weller, M S, Weidinger, S, Deleuran, M, Taieb, A, Paul, C, Trzeciak, M, Werfel, T, Seneschal, J, Barbarot, S, Darsow, U, Torrelo, A, Stalder, J-F, Svensson, Å, Hijnen, D, Gelmetti, C, Szalai, Z, Gieler, U, De Raeve, L, Kunz, B, Spuls, P, von Kobyletzki, L B, Fölster-Holst, R, Chernyshov, P V, Christen-Zaech, S, Heratizadeh, A, Ring, J & Vestergaard, C 2020, 'European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis', JEADV : journal of the European Academy of Dermatology and Venereology, vol. 34, no. 6, pp. e241-e242. https://doi.org/10.1111/jdv.16411